IL137545A0 - New cytotoxic tris(oxazole)-containing macrolides - Google Patents

New cytotoxic tris(oxazole)-containing macrolides

Info

Publication number
IL137545A0
IL137545A0 IL13754599A IL13754599A IL137545A0 IL 137545 A0 IL137545 A0 IL 137545A0 IL 13754599 A IL13754599 A IL 13754599A IL 13754599 A IL13754599 A IL 13754599A IL 137545 A0 IL137545 A0 IL 137545A0
Authority
IL
Israel
Prior art keywords
represents hydrogen
lower alkyl
macrolides
oxazole
hydrogen
Prior art date
Application number
IL13754599A
Other languages
English (en)
Original Assignee
Inst Biomar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Biomar Sa filed Critical Inst Biomar Sa
Publication of IL137545A0 publication Critical patent/IL137545A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL13754599A 1998-01-27 1999-01-27 New cytotoxic tris(oxazole)-containing macrolides IL137545A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801741.1A GB9801741D0 (en) 1998-01-27 1998-01-27 New cytotoxic tris (oxazole)-containing macrolides
PCT/GB1999/000277 WO1999037653A1 (en) 1998-01-27 1999-01-27 New cytotoxic tris(oxazole)-containing macrolides

Publications (1)

Publication Number Publication Date
IL137545A0 true IL137545A0 (en) 2001-07-24

Family

ID=10825984

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13754599A IL137545A0 (en) 1998-01-27 1999-01-27 New cytotoxic tris(oxazole)-containing macrolides

Country Status (21)

Country Link
US (1) US6391900B1 (cs)
EP (1) EP1051420B1 (cs)
JP (1) JP4511027B2 (cs)
KR (1) KR20010034413A (cs)
CN (1) CN1131869C (cs)
AT (1) ATE229024T1 (cs)
AU (1) AU760184B2 (cs)
BR (1) BR9907748A (cs)
CA (1) CA2319032C (cs)
CZ (1) CZ291931B6 (cs)
DE (1) DE69904294T2 (cs)
DK (1) DK1051420T3 (cs)
ES (1) ES2186324T3 (cs)
GB (1) GB9801741D0 (cs)
HU (1) HUP0101321A3 (cs)
IL (1) IL137545A0 (cs)
MX (1) MXPA00007381A (cs)
PL (1) PL342040A1 (cs)
PT (1) PT1051420E (cs)
RU (1) RU2217433C2 (cs)
WO (1) WO1999037653A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100471727B1 (ko) * 2002-10-14 2005-02-21 학교법인 포항공과대학교 이속사졸린 고리와 불소를 포함하는 거대고리 화합물 및그의 제조방법
CN100360515C (zh) * 2004-04-09 2008-01-09 中国科学院上海药物研究所 抗肿瘤活性成份陵水醇、制备方法和用途
ES2276629B1 (es) * 2005-12-15 2009-04-01 Pharma Mar, S.A. Compuestos antitumorales.
CA2729620A1 (en) * 2008-07-03 2010-01-07 Pharma Mar, S.A. Antitumoral macrolides
KR102491180B1 (ko) 2017-04-27 2023-01-20 파르마 마르 에스.에이. 항종양 화합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6256493A (ja) * 1985-09-06 1987-03-12 Yamanouchi Pharmaceut Co Ltd カビラマイド類
FR2664600B1 (fr) * 1990-07-16 1994-09-02 Rhone Poulenc Sante Nouveau sel derive de la dialcoylaminoalcoyl-sulfonyl-26 pristinamycine iib.
GB9315914D0 (en) * 1993-07-31 1993-09-15 Smithkline Beecham Plc Novel compound
EP0729950A4 (en) * 1994-09-13 2001-02-07 Kyowa Hakko Kogyo Kk ANTI-HIV MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
JP2002501074A (ja) 2002-01-15
ES2186324T3 (es) 2003-05-01
CZ291931B6 (cs) 2003-06-18
AU760184B2 (en) 2003-05-08
DE69904294D1 (de) 2003-01-16
WO1999037653A1 (en) 1999-07-29
DE69904294T2 (de) 2003-08-21
DK1051420T3 (da) 2002-12-30
KR20010034413A (ko) 2001-04-25
MXPA00007381A (es) 2002-06-04
CN1131869C (zh) 2003-12-24
CZ20002754A3 (cs) 2002-02-13
EP1051420A1 (en) 2000-11-15
PL342040A1 (en) 2001-05-21
RU2217433C2 (ru) 2003-11-27
CA2319032A1 (en) 1999-07-29
BR9907748A (pt) 2000-10-17
GB9801741D0 (en) 1998-03-25
PT1051420E (pt) 2003-02-28
HUP0101321A3 (en) 2002-06-28
AU2431999A (en) 1999-08-09
US6391900B1 (en) 2002-05-21
CA2319032C (en) 2009-09-08
HUP0101321A2 (hu) 2001-09-28
JP4511027B2 (ja) 2010-07-28
CN1320127A (zh) 2001-10-31
ATE229024T1 (de) 2002-12-15
EP1051420B1 (en) 2002-12-04

Similar Documents

Publication Publication Date Title
SI1037607T1 (en) Novel suppository form comprising an acid-labile active compound
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
GB0013407D0 (en) Forms of a chemical compound
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
AU3633101A (en) Glass-ceramic seals for ceramic membrane chemical reactor application
SG165987A1 (en) Substituted benzoxazoles and analogues as estrogenic agents
AU8386398A (en) Face seal for respirator
NZ333588A (en) Sulphamates as anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS)
SI1385514T1 (sl) Spiroindenske in spiroindanske spojine
PL367940A1 (en) Antitumoral analogs
GB9917132D0 (en) A gas generating apparatus for emergency refuge implements
AU2447899A (en) Apparatus for observing a hostile environment
WO2002059368A8 (en) Specific mucin expression as a marker for pancreatic cancer
GB9801741D0 (en) New cytotoxic tris (oxazole)-containing macrolides
SI1325022T1 (sl) Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op)
JO2065B1 (en) Tri-azin compounds
YU18801A (sh) Eletriptan hidrobromid monohidrat
SI1529777T1 (sl) Postopek inoksazolidinski intermediat za pripravo taksanov
SI1347984T1 (en) A process for the preparation of taxan derivatives
AU1160700A (en) Ppar gamma ligands
GB9913342D0 (en) Seals for down-hole drills
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
EP0900785A3 (en) Vitamin A related compounds and process for producing the same
SG155066A1 (en) Oxetane compounds containing styrenic functionality
GB9902068D0 (en) Compounds